Clinical Trials Directory

Trials / Completed

CompletedNCT06496113

Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma

Recurrence ad Survival After Robotic Versus Laparoscopic Liver Resection in Very-early to Early (BCLC 0-A) Hepatocellular Carcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
196 (actual)
Sponsor
Ente Ospedaliero Cantonale, Bellinzona · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of the study is to investigate the long-term outcomes of minimally invasive liver surgery (robotic vs laparoscopic) for hepatocellular carcinoma patients of stage BCLC 0-A. Data from two tertiary centers for liver surgery will be retrospectively reviewed. Patients will be divided in two cohorts (robot; laparoscopy). The primary endpoint will be recurrence-free and overall survival; secondary endpoints were incidence, pattern, and treatment of recurrences.

Conditions

Interventions

TypeNameDescription
PROCEDUREMinimally invasive liver resectionPatients underwent liver resection either by robotic or laparoscopic approach

Timeline

Start date
2014-01-01
Primary completion
2024-04-01
Completion
2024-06-01
First posted
2024-07-11
Last updated
2024-07-11

Source: ClinicalTrials.gov record NCT06496113. Inclusion in this directory is not an endorsement.

Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma (NCT06496113) · Clinical Trials Directory